What is known about this subject
- HCC is often diagnosed at an advanced stage due to its obscurity,
rapid proliferation and metastasis, where only systemic treatment can
be offered.
- The investigation regarding the clinical significance of PD-1-targeted
immunotherapy in Chinese patients is rare.
- Three PD-1 antibodies approved by the NMPA of China, Toripalimab,
Camrelizumab and Sintilimab, have notable price advantage than
Nivolumab and pembrolizumab.